dc.creatorAraya,Pamela
dc.creatorVelasco,Maritza
dc.creatorTognarelli,Javier
dc.creatorArias,Fabiola
dc.creatorLeiva,Tamara
dc.creatorSccapatticio,Angélica
dc.creatorAlviz,Pablo
dc.creatorFernández,Jorge
dc.date2011-04-01
dc.date.accessioned2017-03-07T16:38:03Z
dc.date.available2017-03-07T16:38:03Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000400008
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/404950
dc.descriptionBackground: The incidence of acquired resistance to antituberculous drugs of Mycobacterium tuberculosis in Chile is approximately 23%. Aim: To analyze the mutations associated with drug resistance in drug resistant strains of Mycobacterium tuberculosis. Material and Methods: In 28 drug resistant Mycobacterium tuberculosis strains isolated in Chile, genes leading to drug resistance were studied. DNA was amplifed by polymerase chain reaction (PCR) and sequencing was carried out using the ABI PRISM big dye terminator cycle sequencing ready reaction kit. Results: In rifampicin-resistant strains, the mutations in rpoβ gene were in the codons S531W/L (56%), D516Y (16%) and D516V (16%). The predominant mutation in katG gene was in the codon S315L (73%) in isoniazid-resistant strains. The mutation S95T was found in the 71% of ciprofoxacin resistant strains. Only one ethambutol resistant strain had the M306I mutation. Three unreported mutations in katG were identifed. Conclusions: Drug resistance associated mutations of Mycobacterium tuberculosis isolated in Chile were similar to those reported abroad.
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.139 n.4 2011
dc.subjectDrug resistance
dc.subjectmicrobial
dc.subjectMutation
dc.subjectMycobacterium tuberculosis
dc.titleDetección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución